FDA

FDA Forces Hims & Hers to Drop Cheap ‘Wegovy’ Knockoff After Regulatory Threats

Hims & Hers cancels its low-cost Wegovy knockoff pill after FDA threats and legal pressure, highlighting regulatory enforcement.

FDA Expands ‘No Artificial Colors’

The Food and Drug Administration (FDA) announced that it has expanded the "no artificial colors" label to be used by companies and their products.

FDA Expands COVID Vaccine-Linked Death Probe

The Food and Drug Administration (FDA) is investigating whether COVID-19 vaccines are linked to adult deaths.

FDA Officer Admits Vaccine Claimed Young Lives

FDA Chief Medical Officer and Center for Biologics Evaluation and Research Director Vinay Prasad has called for the agency to reflect following reports that children's deaths are linked to the COVID-19 vaccine.

FDA Pulls Plug on Children’s Fluoride

The Food and Drug Administration moved to limit the use of unapproved fluoride products for children, taking action to restrict their sale.

Tylenol Criticizes Calls for Label Shifts

Tylenol manufacturer Kenvue Brands LLC sent a letter to the Food and Drug Administration, criticizing demands that the drug's label be changed to reflect greater safety warnings.

FDA Launches Fast-Track Program for New Drugs

The FDA announced the first round of pharmaceuticals that will receive expedited reviews under the Commissioner’s National Priority Voucher (CNPV) pilot program.

FDA Approves Abortion Pill

The Food and Drug Administration approved a generic abortion pill.

Walmart Removing Dyes from Products

Walmart announced that it will remove synthetic dyes from its products.

FDA Begins Label Changes for Tylenol

The Food and Drug Administration (FDA) announced that it has initiated the process of changing the labeling for Tylenol in light of President Trump's announcement that acetaminophen is linked to autism development when used during pregnancy.

Latest news

- Advertisement -spot_img